Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals

Liver Transpl. 2017 Dec;23(12):1628-1629. doi: 10.1002/lt.24962.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents
  • Carcinoma, Hepatocellular*
  • Hepacivirus*
  • Humans
  • Liver Neoplasms
  • Liver Transplantation
  • Waiting Lists

Substances

  • Antiviral Agents